WallStreetZenWallStreetZen

NASDAQ: GRCE
Grace Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Grace Therapeutics earnings were -$7.8M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest GRCE earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$1.2M, down 49.1% from last quarter. For the last reported fiscal year 2026 ending Mar 31, 2026, GRCE reported annual earnings of -$7.8M, with -18.6% growth. The next GRCE earnings date is Aug 11, 2026.

GRCE earnings history

Current Revenue
$0.0
Current Earnings
-$7.8M
Current Profit Margin
0%

GRCE Return on Equity

Current Company
-12.2%
Current Industry
-141.9%
Current Market
13.5%
GRCE's Return on Equity (-12.2%)... subscribe to Premium to read more.
High Return on Equity Performance

GRCE Return on Assets

Current Company
-11.5%
Current Industry
-13.7%
GRCE is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when GRCE announces earnings.

GRCE Return on Capital Employed

Current Company
-14.72%
Current Industry
-9.6%
GRCE has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GRCE vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
GRCE-$9.49M-$7.79MN/A-$0.47
INMB-$41.47M-$41.60MN/A-$1.67
ABVC-$7.88M-$8.63MN/A-$0.39
ACTU-$21.52M-$21.54MN/A-$0.97
NTRB-$7.85M-$29.90MN/A-$2.58
View Top Biotech Stocks

GRCE earnings dates

Next earnings date
Aug 11, 2026

Grace Therapeutics Earnings Reports & History FAQ

What were Grace Therapeutics's earnings last quarter?

Grace Therapeutics (NASDAQ: GRCE) reported Q1 2026 earnings per share (EPS) of -$0.06, up 160% year over year. Total GRCE earnings for the quarter were -$1.18 million. In the same quarter last year, Grace Therapeutics's earnings per share (EPS) was $0.10.

If you're new to stock investing, here's how to buy Grace Therapeutics stock.

When does Grace Therapeutics report earnings?

The next GRCE earnings call is Invalid Date. Add GRCE to your watchlist to be reminded of Grace Therapeutics's next earnings date.

What was GRCE's earnings growth in the past year?

As of Grace Therapeutics's earnings date in Q2 2026, Grace Therapeutics's earnings has grown year over year. GRCE earnings in the past year totalled -$7.79 million.

Is Grace Therapeutics profitable or losing money?

As of the last Grace Therapeutics earnings report, Grace Therapeutics is currently losing money. Grace Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$7.79 million, a 18.55% decrease year over year.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.